How Wegovy and Mounjaro Differ in Practice
Online Prescription Process for Wegovy vs Mounjaro Comparison
Getting an online prescription for either Wegovy or Mounjaro through EverydayMeds removes the complexity of GP referrals and lengthy waiting times. Our streamlined 3-minute clinical assessment evaluates your suitability for both treatments simultaneously, covering medical history, BMI calculations, contraindications, and current medications. This comprehensive approach means your prescriber can recommend the most appropriate option during the same consultation.
The assessment specifically addresses factors that influence the Wegovy vs Mounjaro dose comparison, including your tolerance for injection frequency, storage requirements, and medical conditions that may favour one treatment over another. Licensed UK prescribers review every case individually, ensuring you receive personalised advice rather than a one-size-fits-all approach. Both treatments require the same eligibility criteria, making the online prescription process equally accessible for either option.
Wegovy and Mounjaro Dose Schedule Comparison Pricing
Understanding the cost implications of each dose escalation schedule helps inform your Wegovy vs Mounjaro comparison decision. Wegovy follows a structured 20-week escalation: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), reaching 2.4mg maintenance (£209.99). Our Getting Started bundles like the Intro Trio (0.25mg, 0.5mg, 1mg) cost £299.99, providing three months of dose escalation in one order.
Mounjaro's dose progression differs significantly, starting at 2.5mg and escalating to a maximum 15mg maintenance dose over 16 weeks. When completing your Wegovy vs Mounjaro dose comparison, consider that Wegovy's 6-week room temperature storage advantage may reduce wastage compared to Mounjaro's 21-day limit. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach our competitive pricing structure.
Clinical Evidence Behind the Wegovy Mounjaro Dose Comparison
The clinical foundation supporting each treatment's dose escalation differs substantially in their Wegovy vs Mounjaro comparison profiles. Wegovy's evidence base stems from the STEP trial programme, where patients taking the 2.4mg maintenance dose alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events with Wegovy treatment.
Mounjaro's clinical evidence comes from the SURMOUNT trials, utilising a dual GIP and GLP-1 receptor agonist mechanism compared to Wegovy's GLP-1-only approach. Both treatments require prescription-only medicine status due to their potent effects and need for medical supervision throughout dose escalation phases.
How Wegovy Works in Your Dose Comparison Decision
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This mechanism reduces appetite by acting on brain appetite centres, promoting feelings of fullness after smaller meals, and may reduce food cravings between meals. The once-weekly injection schedule using Novo Nordisk's FlexTouch pen system provides consistent hormone levels throughout the week. Unlike Ozempic, which is licensed for type 2 diabetes only, Wegovy is specifically formulated for weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. The dose escalation from 0.25mg to 2.4mg over 20 weeks allows your body to adjust gradually, minimising side effects whilst building therapeutic effectiveness.
Complete Online Ordering Process for Both Treatments
Our streamlined ordering process eliminates traditional barriers to accessing prescription weight management treatments. The 3-minute online clinical assessment covers medical history, current medications, BMI verification, and contraindication screening for both treatments simultaneously. Licensed UK prescribers review every application within 3 working days as standard, with express 24-hour review available for urgent requirements. Once approved, your chosen treatment ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures every order meets MHRA standards for prescription-only medicine handling and storage.
Storage and Practical Considerations in Your Dose Comparison
Storage requirements play a crucial role in your Wegovy vs Mounjaro dose comparison, particularly if you travel frequently or lack consistent refrigeration access. Wegovy offers superior storage flexibility, maintaining stability for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments arrive in pre-filled FlexTouch pens, eliminating the need for separate needles or complex preparation steps. The dose escalation cannot be skipped for either treatment, as gradual increases help your body adapt whilst minimising gastrointestinal side effects. Wegovy's 5-dose escalation schedule spans 20 weeks compared to Mounjaro's 4-dose escalation over 16 weeks, affecting your long-term supply planning and storage requirements.
Personalised Treatment Selection Through Online Consultation
The online prescription process allows for nuanced decision-making that considers your individual circumstances rather than generic treatment recommendations. Your prescriber evaluates factors like injection tolerance, lifestyle requirements, medical history, and specific weight management goals when recommending between treatments. This personalised approach acknowledges that the optimal choice varies significantly between individuals, even when eligibility criteria are met for both options.
The convenience of online prescribing means you can discuss your Wegovy vs Mounjaro dose comparison concerns directly with qualified prescribers without geographical limitations or appointment availability constraints. Both Wegovy and Mounjaro are available from EverydayMeds, ensuring your prescriber can recommend either treatment based purely on clinical suitability rather than supply limitations.
Secure Your Prescription with Expert Clinical Support
EverydayMeds provides ongoing clinical support throughout your treatment journey, whether you choose Wegovy or Mounjaro following your dose comparison consultation. Our clinical team remains available for dose escalation guidance, side effect management, and treatment optimisation advice. New customers can begin their online assessment today using code FIRST40, whilst returning customers apply DOSE25 at checkout for continued savings. The combination of expert prescriber guidance, competitive pricing, and reliable cold-chain delivery makes EverydayMeds the preferred choice for accessing prescription weight management treatments online. Visit https://everydaymeds.co.uk/collections/wegovy to begin your 3-minute clinical assessment and receive professional guidance on your Wegovy vs Mounjaro treatment decision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
